Prosecution Insights
Last updated: April 19, 2026

Ksq Therapeutics Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18547627 METHODS FOR EXPANDING REGULATORY T CELLS ALDARONDO, DASIA ALI 1647 Non-Final OA Aug 23, 2023
18065464 GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY LEONARD, ARTHUR S 1631 Non-Final OA Dec 13, 2022
18000500 NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS WHITE, DAWANNA SHAR-DAY 1627 Non-Final OA Dec 01, 2022
17779458 METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Nov 22, 2022
17426059 GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY SULLIVAN, STEPHANIE LAUREN 1635 Non-Final OA Jul 27, 2021
16781732 COMBINATION GENE TARGETS FOR IMPROVED IMMUNOTHERAPY SHIN, DANA H 1635 Non-Final OA Feb 04, 2020

Managing Ksq Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month